Patents by Inventor Andrew H. Limper

Andrew H. Limper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6015700
    Abstract: A nucleic acid and corresponding polypeptide that aids in the regulation of the cell cycle in Pneumocystis carinii is described. Antibodies generated against a unique carboxyl-terminus region of the polypeptide have specific binding affinity for P. carinii Cdc2 polypeptide and are benificial in diagnosing and monitoring P. carinii infection in patients. Expression of P. carinii Cdc2 polypeptide in cdc2-mutant yeast and other cdc2-mutant organisms provides a for model for studying the life cycle of P. carinii and for identifying novel therapeutics.
    Type: Grant
    Filed: June 8, 1998
    Date of Patent: January 18, 2000
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Andrew H. Limper, Edward B. Leof, Charles F. Thomas, Michael P. Gustafson
  • Patent number: 5863741
    Abstract: A nucleic acid and corresponding polypeptide that aids in the regulation of the cell cycle in Pneumocystis carinii is described. Antibodies generated against a unique carboxyl-terminus region of the polypeptide have specific binding affinity for P. carinii Cdc2 polypeptide and are beneficial in diagnosing and monitoring P. carinii infection in patients. Expression of P. carinii Cdc2 polypeptide in cdc2-mutant yeast and other cdc2-mutant organisms provides a useful model for studying the life cycle of P. carinii and for identifying novel therapeutics.
    Type: Grant
    Filed: June 13, 1997
    Date of Patent: January 26, 1999
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Andrew H. Limper, Edward B. Leof, Charles F. Thomas, Michael P. Gustafson